Quantitative proteomic analysis of retina in oxygen-induced retinopathy mice using itraq with 2D nanolc-nanoesi-MS/MS

Journal of Integrated OMICS

Volumn 1, Issue 2, 2011, Pages 226-235

  Zhou, Lei ^a,b   Xinling, Liu ^c   Koh, Siew Kwan ^a   Xiaorong, Li ^c   Beuerman, Roger W ^a,b  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

2D nano LC nanoESI MS MS; ITRAQ; Oxygen induced retinopathy; Retina neovascularization; Retina proteome

Indexed keywords

EID: 84866057223     PISSN: None     EISSN: 21820287     Source Type: Journal    
DOI: 10.5584/jiomics.v1i2.36     Document Type: Article

References (47)

1. Ray F. Gariano, Thomas W. Gardner. Retinal angiogenesis in development and disease. Nature. 2005; 438(15); 960-966.
2. Sjolie AK, Stephenson J, Aldington S, Kohner E, Janka H, et al. Retinopathy and vision loss in insulin dependent diabetes in Europe: the EURODIAB IDDM Complications Study. Ophthalmology. 1997; 104:252–260.
3. Kramerov A, Saghizadeh M, Pan H, Kabosova A, Montenarh M. Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina. Am J Pathol. 2006;168(5):1722-36
4. Kimura T, Takagi H, Suzuma K, Kita M, Watanabe D, et al. Comparisons between the beneUcial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization. Free Radic Biol Med. 2007; 43(3):454-61.
5. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci, 1994, 35(1):101-111.
6. Michael Dorrell, Hannele Uusitalo-Jarvinen, Edith Aguilar, and Martin Friedlander. Ocular Neovascularization: Basic Mechanisms and Therapeutic Advances. Survey Of Ophthalmology, 2007; 52: S3-S19
7. Sarah X. Zhang, Jian-xing Ma. Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy. Progress in Retinal and Eye Research 2007; 26:1–37.
8. Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med. 1999; 5:1390–1395.
9. Sarlos S, Rizkalla B, Moravski CJ, Cao Z, Cooper ME, et al. Retinal angiogenesis is mediated by an interaction between the angiotensin type2 receptor, VEGF, and angiopoietin. Am J Pathol, 2003; 163(3):879-887.
10. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, et al. Pigment epithelium derived factor: a potent inhibitor of angiogenesis. Science. 1999; 285:245–248.
11. Kvanta A. Ocular angiogenesis: the role of growth factors. Acta Ophthalmol Scand. 2006; 84(3):282-8.
12. Yoshida S, Yoshida A, Ishibashi T. Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during a\er ischemic in[ammation. Graefes Arch Clin Exp Ophthalmol, 2004; 242:409–413.
13. Aiello, L.P., Pierce, E.A., Foley, E.D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G.L., Smith, L.E.,. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 1995 92, 10457–10461.
14. Das, A., McGuire, P.G.,. Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Prog. Retin. Eye Res. 2003; 22, 721–748.
15. Liu Q, Tan G, Levenkova N, Li T, Pugh EN, Rux J, Speicher DW, Pierce EA. the proteome of the mouse photoreceptor sensory cilium complex. Mol Cell Proteomics. 2007 May 9;
16. Haniu H, Komori N, Takemori N, Singh A, Ash JD, Matsumoto H. Proteomic trajectory mapping of biological transformation: Application to developmental mouse retina. Proteomics. 2006; 6(11):3251-61.
17. Cavusoglu N, Thierse D, Mohand-Saïid S, Chalmel F, Poch O, Van-Dorsselaer A, Sahel JA, Léveillard T. Differential proteomic analysis of the mouse retina: the induction of crystallin proteins by retinal degeneration in the rd1 mouse. Mol Cell Proteomics. 2003; 2(8):494-505.
18. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, et al. Drusen proteome analysis：an approach to the etiology of age related macular degeneration. Proc Natl Acad Sci, 2002; 99:14682-14687.
19. Haniu H, Komori N, Takemori N, Singh A, Ash JD, et al. Proteomic trajectory mapping of biological transformation: Application to developmental mouse retina. Proteomics. 2006; 6 (11):3251-61.
20. Godfrey J. Quin, Alice C. L. Len, Frank A. Billson, Mark C. Gillies. Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: New insight in the pathogenesis of diabetic retinopathy. 2007; 7:2636-2650.
21. Curtis L. Nordgaard, Kristin M. Berg, Rebecca J. Kapphahn, Cavan Reilly, Xiao Feng, et al. Proteomics of the Retinal Pig ment Epithelium Reveals Altered Protein Expression at Progressive Stages of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 2006, 47;3; 815-822.
22. Higgins RD, Yu K, Sanders RJ, et al. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res 1999; 18: 20-7
23. Zhi-Liang Hu, Jie Bao and James M. Reecy (2008) "CateGOrizer: A Web-Based Program to Batch Analyze Gene Ontology ClassiUcation Categories". Online Journal of Bioinformatics. 9 (2):108-112.
24. Sato T, Kusaka S, Hashida N, Saishin Y, Fujikado T, Tano Y. Comprehensive gene-expression proUle in murine oxygeninduced retinopathy. Br J Ophthalmol. 2009 Jan;93(1):96-103.
25. Bresgen M, Baum U, Esser P, Wiedemann P, Heimann K. Protein composition of the vitreous body in proliferative diabetic retinopathy. An analysis with 2D-electrophoresis. Ophthalmologe. l994; 91: 758-762.
26. Nakanishi T, Koyama R, Ikeda T, Shimizu A. Catalogue of soluble proteins in the human vitreous humor:comparison between diabetic retinopathy and macular hole. J Chromatogr B Analyt Technol Biomed Life Sci, 2002; 776:89-l00.
27. García-Ramírez M, Canals F, Hernández C, Colomé N, Ferrer C, et al. Proteomic analysis of human vitreous [uid by [uorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia. 2007; 50 (6):1294-1303.
28. Nakazawa T, Takeda M, Lewis GP, Cho KS, Jiao J, Wilhelmsson U, Fisher SK, Pekny M, Chen DF, Miller JW. Attenuated glial reactions and photoreceptor degeneration a\er retinal detachment in mice deUcient in glial Ubrillary acidic protein and vimentin. Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2760-8.
29. Mager WH. Control of ribosomal protein gene expression. Biochim. Biophys Acta. 1988; 949:1–15.
30. Wool IG, Chan Y-L, Gluck A. Structure and evolution of mammalian ribosomal proteins. Biochem Cell Biol. 1995; 73: 933–947.
31. Bevort M, Leffers H. Down regulation of ribosomal protein mRNAs during neuronal differentiation of human NTERA2 cells. Differentiation. 2000; 66:81–92.
32. Ben-Ishai R, Scharf R, Kapten I. A human cellular sequence implicated in trk oncogene activation is DNA damage inducible. Prod Natl Acad Sci USA. 1990;87: 6039–6043.
33. Jamieson KV, Wu J, Hubbard SR, Meruelo D. Crystal structure of the human laminin receptor precursor. J Biol Chem. 2008 Feb 8;283(6):3002-5. Epub 2007 Dec 6.
34. Mafune K, Ravikumar TS, Wong JM, et al. Expression of a Mr 32,000 laminin-binding protein messenger RNA in human colon carcinoma correlates with disease progression. Cancer Res, 1990; 50:3888–3891.
35. Yingfei Wang, Weibo Luo, Thomas Wartmann, Walter Halangk, Miklos Sahin-Tùth and Georg Reiser. Mesotrypsin, a brain trypsin, activates selectively proteinase-activated receptor -1, but not proteinase-activated receptor-2, in rat astrocytes. Journal of Neurochemistry, 2006; Volume 99 Issue 3 Page 759-769.
36. Foekens JA, Look MP, Bolt-de Vries J, Meijer-van Gelder ME, van Putten WL, et al. Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer. 1999 Jan;79(2):300-7.
37. Laurent-Matha V, Maruani-Herrmann S, Prebois C, Beaujouin M, Glondu M,Catalytically inactive human cathepsin D triggers Ubroblast invasive growth. J Cell Biol. 2005 Jan 31;168 (3):489-99.
38. Ricard CS, Kobayashi S, Pena JD, Salvador-Silva M, Agapova O, Hernandez MR. Selective expression of neural cell adhesion molecule (NCAM)-180 in optic nerve head astrocytes exposed to elevated hydrostatic pressure in vitro. Brain Res Mol Brain Res. 2000 Sep 30;81(1-2):62-79.
39. Reid SN, Yamashita C, Farber DB. Retinoschisin, a photoreceptor-secreted protein, and its interaction with bipolar and muller cells. J Neurosci. 2003 Jul 9;23(14):6030-40.
40. Sax C, Piatigorsky J. Expression of the α-crystallin/small heatshock protein/molecular chaperone genes in the lens and other tissues. In: Meister A, editor. Advances in enzymology and related areas of molecular biology. Vol 69 New York: Wiley Interscience; 1994:155-201.
41. Jinghua Xi, Rafal Farjo, Shigeo Yoshida, et al. A comprehensive analysis of the expression of crystallins in mouse retina. Molecular Vision 2003; 9:410-9
42. Ahmed F, Brown KM, Stephan DA, Morrison JC, Johnson EC, Tomarev SI. Microarray analysis of changes in mRNA levels in the rat retina a\er experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci 2004; 45:1247-58.
43. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci 2006; 47:977-85
44. Sakaguchi H, Miyagi M, Darrow RM, Crabb JS, HollyUeld JG, Organisciak DT, Crabb JW. Intense light exposure changes the crystallin content in retina. Exp Eye Res 2003; 76:131-3.
45. Vazquez-Chona F, Song BK, Geisert EE Jr. Temporal changes in gene expression a\er injury in the rat retina. Invest Ophthalmol Vis Sci 2004; 45:2737-46.
46. Jones SE, Jomary C, Grist J, Thomas MR, Neal MJ. Expression of alphaB-crystallin in a mouse model of inherited retinal degeneration. Neuroreport 1998; 9:4161-5.
47. Farjo R, Kern TS, Andley UP, Swaroop A. Microarray analysis of mouse models of diabetic retinopathy reveals dramatic modulation of crystallin genes in the retina. ARVO Annual Meeting, 2003 May 4-9.